Asia Pacific Neurological Biomarker Market : Table of Contents

1. Introduction

1.1 Report Guidance

1.2 Market Segmentation

2. Executive Summary

2.1 Key Market Insights

2.2 Market Attractiveness

3. Research Methodology

3.1 Secondary Research

3.2 Primary Research

3.2.1 Data Triangulation and Validation

4. Asia Pacific Neurological Biomarker Market Landscape

4.1 Overview

4.3 Ecosystem Analysis

4.3.1 List of Vendors in the Value Chain

5. Asia Pacific Neurological Biomarker Market – Key Market Dynamics

5.1 Market Drivers

5.2 Market Restraints

5.3 Market Opportunities

5.4 Future Trends

5.5 Impact of Drivers and Restraints

6. Asia Pacific Neurological Biomarker Market Regional Analysis

6.2 Asia Pacific Neurological Biomarker Market Revenue 2017-2027 (US$ Million)

6.3 Asia Pacific Neurological Biomarker Market Forecast Analysis

7. Asia Pacific Neurological Biomarker Market Analysis – by Product

7.1 Proteomics Biomarker

7.1.1 Overview
7.1.2 Proteomics Biomarker: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.2 Genomics Biomarker

7.2.1 Overview
7.2.2 Genomics Biomarker: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.3 Metabolomics Biomarker

7.3.1 Overview
7.3.2 Metabolomics Biomarker: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

7.4 Imaging Biomarker

7.4.1 Overview
7.4.2 Imaging Biomarker: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

8. Asia Pacific Neurological Biomarker Market Analysis – by Application

8.1 Alzheimer's Disease

8.1.1 Overview
8.1.2 Alzheimer's Disease: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.2 Parkinson's Disease

8.2.1 Overview
8.2.2 Parkinson's Disease: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.3 Schizophrenia

8.3.1 Overview
8.3.2 Schizophrenia: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.4 Huntington's Disease

8.4.1 Overview
8.4.2 Huntington's Disease: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

8.5 Spinal Muscular Atrophy

8.5.1 Overview
8.5.2 Spinal Muscular Atrophy: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

9. Asia Pacific Neurological Biomarker Market Analysis – by End User

9.1 Pharmaceutical and Biotechnology Companies

9.1.1 Overview
9.1.2 Pharmaceutical and Biotechnology Companies: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.2 Clinical Diagnostics

9.2.1 Overview
9.2.2 Clinical Diagnostics: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

9.3 Research Organizations

9.3.1 Overview
9.3.2 Research Organizations: Asia Pacific Neurological Biomarker Market – Revenue and Forecast, 2017-2027 (US$ Million)

10. Asia Pacific Neurological Biomarker Market – Asia-Pacific Analysis

10.1 Overview

10.2 Asia-Pacific

10.2.1 Asia Pacific Neurological Biomarker Market Breakdown, by Key Country, 2020 and 2027 (%)
10.2.1.1 Asia Pacific Neurological Biomarker Market – Revenue and Forecast Analysis – by Country
10.2.1.1 China: Asia Pacific Neurological Biomarker Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.1.1 China: Asia Pacific Neurological Biomarker Market Breakdown, by Product
10.2.1.1.2 China: Asia Pacific Neurological Biomarker Market Breakdown, by Application
10.2.1.1.3 China: Asia Pacific Neurological Biomarker Market Breakdown, by End User

10.2.1.2 India: Asia Pacific Neurological Biomarker Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.2.1 India: Asia Pacific Neurological Biomarker Market Breakdown, by Product
10.2.1.2.2 India: Asia Pacific Neurological Biomarker Market Breakdown, by Application
10.2.1.2.3 India: Asia Pacific Neurological Biomarker Market Breakdown, by End User

10.2.1.3 Japan: Asia Pacific Neurological Biomarker Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.3.1 Japan: Asia Pacific Neurological Biomarker Market Breakdown, by Product
10.2.1.3.2 Japan: Asia Pacific Neurological Biomarker Market Breakdown, by Application
10.2.1.3.3 Japan: Asia Pacific Neurological Biomarker Market Breakdown, by End User

10.2.1.4 Australia: Asia Pacific Neurological Biomarker Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.4.1 Australia: Asia Pacific Neurological Biomarker Market Breakdown, by Product
10.2.1.4.2 Australia: Asia Pacific Neurological Biomarker Market Breakdown, by Application
10.2.1.4.3 Australia: Asia Pacific Neurological Biomarker Market Breakdown, by End User

10.2.1.5 Rest of Asia-Pacific : Asia Pacific Neurological Biomarker Market – Revenue and Forecast to 2027 (US$ Million)

10.2.1.5.1 Rest of Asia-Pacific : Asia Pacific Neurological Biomarker Market Breakdown, by Product
10.2.1.5.2 Rest of Asia-Pacific : Asia Pacific Neurological Biomarker Market Breakdown, by Application
10.2.1.5.3 Rest of Asia-Pacific : Asia Pacific Neurological Biomarker Market Breakdown, by End User

11. Competitive Landscape

11.1 Heat Map Analysis

11.2 Company Positioning and Concentration

12. Industry Landscape

12.1 Overview

12.2 Market Initiative

12.3 Partnerships and Collaborations

12.4 Other Developments

13. Company Profiles

13.1 Thermo Fisher Scientific Inc.

13.1.1 Key Facts
13.1.2 Business Description
13.1.3 Products and Services
13.1.4 Financial Overview
13.1.5 SWOT Analysis
13.1.6 Key Developments

13.2 Abbott

13.2.1 Key Facts
13.2.2 Business Description
13.2.3 Products and Services
13.2.4 Financial Overview
13.2.5 SWOT Analysis
13.2.6 Key Developments

13.3 Bio-Rad Laboratories Inc.

13.3.1 Key Facts
13.3.2 Business Description
13.3.3 Products and Services
13.3.4 Financial Overview
13.3.5 SWOT Analysis
13.3.6 Key Developments

13.4 QIAGEN

13.4.1 Key Facts
13.4.2 Business Description
13.4.3 Products and Services
13.4.4 Financial Overview
13.4.5 SWOT Analysis
13.4.6 Key Developments

13.5 Immunarray Pvt. Ltd.

13.5.1 Key Facts
13.5.2 Business Description
13.5.3 Products and Services
13.5.4 Financial Overview
13.5.5 SWOT Analysis
13.5.6 Key Developments

13.6 Quest Diagnostics Incorporated

13.6.1 Key Facts
13.6.2 Business Description
13.6.3 Products and Services
13.6.4 Financial Overview
13.6.5 SWOT Analysis
13.6.6 Key Developments

13.7 Perkin Elmer, Inc

13.7.1 Key Facts
13.7.2 Business Description
13.7.3 Products and Services
13.7.4 Financial Overview
13.7.5 SWOT Analysis
13.7.6 Key Developments

13.8 MERCK KGaA

13.8.1 Key Facts
13.8.2 Business Description
13.8.3 Products and Services
13.8.4 Financial Overview
13.8.5 SWOT Analysis
13.8.6 Key Developments

14. Appendix

14.1 About Business Market Insights

14.2 List of Abbreviations

Asia Pacific Neurological Biomarker Market